Iovance Biotherapeutics Overview
Iovance Biotherapeutics Target Price
Analysts' 12-month price predictions for IOVA.
Share Price
$12.88
Average Target Price
$19.00
47.5% upside
47.5% upside1 analysts in the last 4 months
High: $19 | Low: $19
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-03-14 | Piper SandlerJoseph Catanzaro | $19 | 47.5% upside |  |
| 2022-12-08 | Goldman SachsMadhu Kumar | $6 |  53.4% downside | |
| 2022-11-20 | Piper SandlerJoseph Catanzaro | $11 | 14.6% downside | |
| 2022-08-23 | Robert W. BairdMichael Ulz | $25 | 94.1% upside | |
| 2022-07-01 | Goldman Sachs | $18 | 39.8% upside | |
| 2022-05-27 | Stifel Nicolaus | $13 | 0.9% upside | |
| 2022-04-07 | Robert W. BairdColleen Kusy | $34 | 164% upside | |
| 2022-04-05 | Robert W. BairdColleen M. Kusy | $30 | 132.9% upside | |
| 2022-01-28 | Stifel NicolausBenjamin Burnett | $25 | 94.1% upside | |
| 2022-01-05 | Wells FargoNick Abbott | $25 | 94.1% upside | |
| 2021-05-19 | BarclaysPeter Lawson | $40 | 210.6% upside | |